FDA Approves, Leqembi, New Treatment for Early Alzheimer’s – The New York Times

January 5, 2023 by quixnet

FDA Approves, Leqembi, New Treatment for Early Alzheimer’sThe New York Times
New Alzheimer’s drug offers hope to patients and caregivers | DW NewsDW News
Alzheimer’s drug lecanemab receives accelerated approval amid safety concernsCNN
FDA approves Alzheimer’s drug that slowed cognitive decline in clinical trialCNBC
Alzheimer’s drug decision day: FDA to decide on Biogen and Eisai treatmentsCNBC Television